epa08600510 A handout photo made available by the Russian Direct Investment Fund (RDIF) shows a scientist of Nikolai Gamaleya National Center of Epidemiology and Microbiology working on the production of a new two-vector COVID-19 vaccine in Moscow, Russia, 06 August 2020 (issued 13 August 2020). Russia registered the new called Sputnik V vaccine against the coronavirus Sars-Cov-2 and opens the stage of its massive testing.  EPA/RDIF HANDOUT NO RESTRICTIONS, ALLOW TO USE IN SOCIAL NETWORK HANDOUT EDITORIAL USE ONLY/NO SALES
epa08600510 A handout photo made available by the Russian Direct Investment Fund (RDIF) shows a scientist of Nikolai Gamaleya National Center of Epidemiology and Microbiology working on the productionShow more

Russia starts production of Covid-19 vaccine


The National


View from London

Your weekly update from the UK and Europe

      By signing up, I agree to The National's privacy policy
      View from London